FDA
approval
· 2020-12-28
FDA Approved: GLUCAGON — Original Application (Amphastar Pharmaceuticals, Inc.)
Summary
The FDA approved Amphastar Pharmaceuticals' original application for a generic glucagon product to treat severe hypoglycemia in patients with diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GLUCAGON (GLUCAGON)